In addition to routine FISH use at AML diagnosis, incorporation of a novel clinical assay based on RNA-sequencing or whole genome sequencing would improve the detection of cryptic KMT2A translocations [31–33]. Here, KMT2A is linked to acute myeloid leukemia.